Revance Therapeutics Inc logo

Revance Therapeutics Inc

STU:RTI (USA)  
€ 4.66 (+0.87%) Oct 4
At Loss
Market Cap:
€ 492.81M ($ 541.19M)
Enterprise V:
€ 727.87M ($ 799.33M)
Volume:
-
Avg Vol (2M):
600.00
Trade In:

Revance Therapeutics Inc Valuation Measures